EMILY RAMSEY: Open Payments
NPI 1023745973 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 25 payments from 12 companies in 2025. Trend: 2023 $471 · 2024 $264 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Janssen Biotech, Inc. | 1 | $75 |
| PFIZER INC. | 4 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $39 |
| PharmaEssentia USA Corporation | 2 | $38 |
| SOBI, INC | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Iovance Biotherapeutics, Inc. | 1 | $19 |
Products named: RYBREVANT, CALQUENCE, KISQALI, IBRANCE, BESREMI, EPKINLY, LYNPARZA, WELIREG.
Industry payments across GA — which companies pay providers there.
